NAFLD/NASH: Updates & Treatment Options
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Nonalcoholic fatty liver disease and steatohepatitis are well-recognized clinical concerns. What are we learning from the latest research? What is the diagnostic value of liver biopsy? Dr. Naga Chalasani, professor of medicine in the division of gastroenterology and hepatology at Indiana University School of Medicine, also examines the manifestation and risk profile of each disease with host Dr. Jay Goldstein. How do statins factor into current treatment patterns?
Overview
Nonalcoholic fatty liver disease and steatohepatitis are well-recognized clinical concerns. What are we learning from the latest research? What is the diagnostic value of liver biopsy? Dr. Naga Chalasani, professor of medicine in the division of gastroenterology and hepatology at Indiana University School of Medicine, also examines the manifestation and risk profile of each disease with host Dr. Jay Goldstein. How do statins factor into current treatment patterns?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?